Literature DB >> 2204413

Membranous nephropathy in childhood and its treatment.

J S Cameron1.   

Abstract

Membranous nephropathy is predominantly a disease of middle-aged and elderly individuals, and is thus rather an uncommon finding in proteinuric and nephrotic children. In children, it differs in several important respects from the disease as seen in adults: an apparent associated cause is more common, macroscopic haematuria is seen quite frequently, a relapsing course is more often noted, renal venous thrombosis is not found and evolution into renal failure is the exception. Nevertheless, a proportion of children with membranous nephropathy do evolve into renal failure, and their management is discussed with particular reference to recent papers on the treatment of membranous nephropathy in adults. An aggressive search for associated disease is worthwhile in children, and one should wait to see what the evolution or proteinuria and renal function may be. If a progressive course becomes evident, then a trial of treatment with corticosteroids is worthwhile, but if this is ineffective then a more aggressive approach involving the use of alkylating agents may be justified. It remains undetermined what the best regime in children and adolescents may be.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2204413     DOI: 10.1007/bf00858840

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  44 in total

Review 1.  Interaction of antibodies with renal cell surface antigens.

Authors:  J R Brentjens; G Andres
Journal:  Kidney Int       Date:  1989-04       Impact factor: 10.612

2.  Nephrotic syndrome of congenital syphilis. Biopsy studies in four cases.

Authors:  R O Kaschula; C J Uys; R H Kuijten; J R Dale; J Wiggelinkhuizen
Journal:  Arch Pathol       Date:  1974-05

3.  Persistent proteinuria in children.

Authors:  Y C Tsao; W C Chan; J B Gibson
Journal:  Arch Dis Child       Date:  1969-08       Impact factor: 3.791

4.  Idiopathic membranous nephropathy in children.

Authors:  H Olbing; I Greifer; B P Bennett; J Bernstein; A Spitzer
Journal:  Kidney Int       Date:  1973-06       Impact factor: 10.612

5.  A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis.

Authors:  M L West; K K Jindal; R A Bear; M B Goldstein
Journal:  Kidney Int       Date:  1987-10       Impact factor: 10.612

6.  The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party.

Authors:  J S Cameron; M J Healy; D Adu
Journal:  Q J Med       Date:  1990-02

7.  Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndrome.

Authors:  P Guesry; G Lenoir; M Broyer
Journal:  J Pediatr       Date:  1978-02       Impact factor: 4.406

8.  The clinical spectrum of renal vein thrombosis: acute and chronic.

Authors:  F Llach; S Papper; S G Massry
Journal:  Am J Med       Date:  1980-12       Impact factor: 4.965

9.  Methylprednisolone in patients with membranous nephropathy and declining renal function.

Authors:  C D Short; L R Solomon; R Gokal; N P Mallick
Journal:  Q J Med       Date:  1987-11

10.  The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults.

Authors:  A M Davison; J S Cameron; D N Kerr; C S Ogg; R W Wilkinson
Journal:  Clin Nephrol       Date:  1984-08       Impact factor: 0.975

View more
  19 in total

1.  Childhood membranous nephropathy in association with interstitial nephritis and Fanconi syndrome.

Authors:  Mohan Shenoy; Rajesh Krishnan; Nadeem Moghal
Journal:  Pediatr Nephrol       Date:  2005-12-21       Impact factor: 3.714

Review 2.  What is the actual management of a child with membranous glomerulopathy associated with chronic hepatitis B?

Authors:  M C Chiu
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

3.  Proteinuria in a patient with Graves' disease: Questions.

Authors:  Aydilek Dagdeviren Cakir; Nur Canpolat; Seha Saygili; Isin Kilicaslan; Hande Turan; Oya Ercan; Olcay Evliyaoglu
Journal:  Pediatr Nephrol       Date:  2019-03-06       Impact factor: 3.714

4.  Proteinuria in a patient with Graves' disease: Answers.

Authors:  Aydilek Dagdeviren Cakir; Nur Canpolat; Seha Saygili; Isin Kilicaslan; Hande Turan; Oya Ercan; Olcay Evliyaoglu
Journal:  Pediatr Nephrol       Date:  2019-03-06       Impact factor: 3.714

5.  Acute poststreptococcal glomerulo-nephritis in general practice: the contribution of infection to its onset and course.

Authors:  P M Higgins
Journal:  Epidemiol Infect       Date:  1996-04       Impact factor: 2.451

6.  Membranous nephropathy associated with thyroid-peroxidase antigen.

Authors:  Yuko Shima; Koichi Nakanishi; Hiroko Togawa; Mina Obana; Mayumi Sako; Masakazu Miyawaki; Kandai Nozu; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2008-09-02       Impact factor: 3.714

7.  Clinical course and outcome of idiopathic membranous nephropathy in Japanese children.

Authors:  H Tsukahara; Y Takahashi; M Yoshimoto; S Hayashi; S Fujisawa; F Suehiro; K Akaishi; Y Nomura; K Morikawa; M Sudo
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

8.  Membranous glomerulonephritis: treatment response and outcome in children.

Authors:  Rudolph P Valentini; Tej K Mattoo; Gaurav Kapur; Abubakr Imam
Journal:  Pediatr Nephrol       Date:  2008-10-10       Impact factor: 3.714

Review 9.  Recurrent primary disease and de novo nephritis following renal transplantation.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

Review 10.  Membranous nephropathy in children: clinical presentation and therapeutic approach.

Authors:  Shina Menon; Rudolph P Valentini
Journal:  Pediatr Nephrol       Date:  2009-11-12       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.